» Articles » PMID: 20854943

Ameloblastin Expression and Putative Autoregulation in Mesenchymal Cells Suggest a Role in Early Bone Formation and Repair

Overview
Journal Bone
Date 2010 Sep 22
PMID 20854943
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Ameloblastin is mainly known as a dental enamel protein, synthesized and secreted into developing enamel matrix by the enamel-forming ameloblasts. The function of ameloblastin in tooth development remains unclear, but it has been suggested to be involved in processes varying from regulating crystal growth to activity as a growth factor or partaking in cell signaling. Recent studies suggest that some enamel matrix proteins also might have important functions outside enamel formation. In this context ameloblastin has recently been reported to induce dentin and bone repair, as well as being present in the early bone and cartilage extracellular matrices during embryogenesis. However, what cells express ameloblastin in these tissues still remains unclear. Thus, the expression of ameloblastin was examined in cultured primary mesenchymal cells and in vivo during healing of bone defects in a "proof of concept" animal study. Real time RT-PCR analysis revealed human ameloblastin (AMBN) mRNA expression in human mesenchymal stem cells and primary osteoblasts and chondrocytes. Expression of AMBN mRNA was also confirmed in human CD34 positive cells and osteoclasts. Western and dot blot analysis of cell lysates and medium confirmed the expression and secretion of ameloblastin from mesenchymal stem cells, primary human osteoblasts and chondrocytes. Expression of ameloblastin was also detected in newly formed bone in experimental bone defects in adult rats. Together these findings suggest a role for this protein in early bone formation and repair.

Citing Articles

Revisiting ameloblastin; addressing the EMT-ECM axis above and beyond oral biology.

Reseland J, Heyward C, Samara A Front Cell Dev Biol. 2023; 11:1251540.

PMID: 38020879 PMC: 10679718. DOI: 10.3389/fcell.2023.1251540.


Histological evaluation of the effects of bone morphogenetic protein 9 and angiopoietin 1 on bone healing.

Fadhil E, Dosh R, Wally Z, Haider J J Taibah Univ Med Sci. 2023; 18(5):954-963.

PMID: 36875339 PMC: 9982621. DOI: 10.1016/j.jtumed.2023.02.005.


Early evolution of enamel matrix proteins is reflected by pleiotropy of physiological functions.

Spoutil F, Aranaz-Novaliches G, Prochazkova M, Wald T, Novosadova V, Kasparek P Sci Rep. 2023; 13(1):1471.

PMID: 36702824 PMC: 9879986. DOI: 10.1038/s41598-023-28388-4.


The Role of Type VI Collagen in Alveolar Bone.

Komori T, Pham H, Jani P, Perry S, Wang Y, Kilts T Int J Mol Sci. 2022; 23(22).

PMID: 36430826 PMC: 9697549. DOI: 10.3390/ijms232214347.


Comprehensive Analysis Identifies Ameloblastin-Related Competitive Endogenous RNA as a Prognostic Biomarker for Testicular Germ Cell Tumour.

Geng T, Heyward C, Chen X, Zheng M, Yang Y, Reseland J Cancers (Basel). 2022; 14(8).

PMID: 35454778 PMC: 9030878. DOI: 10.3390/cancers14081870.


References
1.
Fong C, Cerny R, Hammarstrom L, Slaby I . Sequential expression of an amelin gene in mesenchymal and epithelial cells during odontogenesis in rats. Eur J Oral Sci. 1998; 106 Suppl 1:324-30. DOI: 10.1111/j.1600-0722.1998.tb02193.x. View

2.
Simmer J, Hu J . Expression, structure, and function of enamel proteinases. Connect Tissue Res. 2002; 43(2-3):441-9. DOI: 10.1080/03008200290001159. View

3.
Smeland E, Rusten L, Jacobsen S, Skrede B, Blomhoff R, Wang M . All-trans retinoic acid directly inhibits granulocyte colony-stimulating factor-induced proliferation of CD34+ human hematopoietic progenitor cells. Blood. 1994; 84(9):2940-5. View

4.
Huang S, Terstappen L . Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cells. Nature. 1992; 360(6406):745-9. DOI: 10.1038/360745a0. View

5.
Mardh C, Backman B, Simmons D, Golovleva I, Gu T, Holmgren G . Human ameloblastin gene: genomic organization and mutation analysis in amelogenesis imperfecta patients. Eur J Oral Sci. 2001; 109(1):8-13. DOI: 10.1034/j.1600-0722.2001.00979.x. View